Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. 2009

Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
INSERM, ERI-20, Institut Gustave Roussy, Villejuif Cedex, France.

Experimental studies suggest detrimental effects of omega-6 polyunsaturated fatty acids (PUFA), and beneficial effects of omega-3 PUFAs on mammary carcinogenesis, possibly in interaction with antioxidants. However, PUFA food sources are diverse in human diets and few epidemiologic studies have examined whether associations between dietary PUFAs and breast cancer risk vary according to food sources or antioxidant intakes. The relationship between individual PUFA intakes estimated from diet history questionnaires and breast cancer risk was examined among 56,007 French women. During 8 years of follow-up, 1,650 women developed invasive breast cancer. Breast cancer risk was not related to any dietary PUFA overall; however, opposite associations were seen according to food sources, suggesting other potential effects than PUFA per se. Breast cancer risk was inversely associated with alpha-linolenic acid (ALA) intake from fruit and vegetables [highest vs. lowest quintile, hazard ratio (HR) 0.74; 95% confidence interval (CI) 0.63, 0.88; p trend < 0.0001], and from vegetable oils (HR 0.83; 95% CI 0.71, 0.97; p trend 0.017). Conversely, breast cancer risk was positively related to ALA intake from nut mixes (p trend 0.004) and processed foods (p trend 0.068), as was total ALA intake among women in the highest quintile of dietary vitamin E (p trend 0.036). A significant interaction was also found between omega-6 and long-chain omega-3 PUFAs, with breast cancer risk inversely related to long-chain omega-3 PUFAs in women belonging to the highest quintile of omega-6 PUFAs (p interaction 0.042). These results emphasize the need to consider food sources, as well as interactions between fatty acids and with antioxidants, when evaluating associations between PUFA intakes and breast cancer risk.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
April 2003, Lipids,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
January 2005, World review of nutrition and dietetics,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
January 1999, Annals of nutrition & metabolism,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
February 2018, The Journal of nutritional biochemistry,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
January 1999, Annals of nutrition & metabolism,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
August 1997, Journal of the National Cancer Institute,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
June 2018, Life sciences,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
March 2010, Carcinogenesis,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
October 2013, Anti-cancer agents in medicinal chemistry,
Anne C M Thiébaut, and Véronique Chajès, and Mariette Gerber, and Marie-Christine Boutron-Ruault, and Virginie Joulin, and Gilbert Lenoir, and Franco Berrino, and Elio Riboli, and Jacques Bénichou, and Françoise Clavel-Chapelon
December 1999, Asia Pacific journal of clinical nutrition,
Copied contents to your clipboard!